Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

计划入组 24 人 · 首次发布于 2018 年 3 月 29 日

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

计划入组 132 人 · 首次发布于 2007 年 6 月 5 日

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

首次发布于 2005 年 4 月 26 日

FFAR4 activator program (severe asthma)

JAK inhibitors (inhaled, severe asthma)

CLS-122

ALLERGY & ASTHMA CLINICAL RESEARCH, INC.

United States

German Asthma Net e.V.

Germany

CALIFORNIA ALLERGY & ASTHMA MEDICAL GROUP, INC.

United States

Engineered CAR-like Tregs Suppress Allergic Asthma in Mice, Offering Blueprint for Novel Allergy Immunotherapy

Kashiv BioSciences Partners with MS Pharma for MENA Launch of Omalizumab Biosimilar ADL-018

Novel Therapies Show Promise for Chronic Spontaneous Urticaria with Complete Response Rates Exceeding 30%